Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop

Brad S. Kahl(UW Health University Hospital), Eduardo M. Sotomayor(Tampa General Hospital), Leo I. Gordon(Northwestern University), Leticia Quintanilla‐Martínez(University Children's Hospital Tübingen), Peter Martin(Northwestern University), Martin Dreyling(LMU Klinikum)
Leukemia & lymphoma/Leukemia and lymphoma
January 30, 2019
10.1080/10428194.2019.1571205
Cited by 10

Related Papers

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k